AmpliVue® assays provide access to all of the benefits of lateral flow molecular testing to any size laboratory. AmpliVue uses Quidel's proprietary Helicase Dependent Amplification (HDA), which you can learn more about here. Quidel wants all labs to have access to the improved specificity, better accuracy and faster results, which molecular provides.
Using a small hand-held cartridge which requires no equipment beyond a thermal block with a heated lid, AmpliVue eliminates the barrier of a large capital investment for molecular testing. AmpliVue assays are also considered CLIA moderately complex, which allows for simple training and freeing high complexity staff to work on other assays. Bringing tests in house, reducing turnaround time, reducing hands-on time and simplifying your workflow are just a few logistical benefits of AmpliVue.
AmpliVue®
-
The AmpliVue Bordetella Assay is an in vitro diagnostic test for the qualitative detection of Bordetella pertussis nucleic acids isolated from nasopharyngeal swab specimens...
-
The AmpliVue C. difficile Assay is an in vitro diagnostic test for the direct, qualitative detection of the Clostridium difficile Toxin A gene (tcdA) in unformed stool specimens...
-
The AmpliVue GBS Assay is an in vitro diagnostic test for the direct, qualitative detection of Group B Streptococcus from vaginal/rectal swabs.
-
The AmpliVue HSV 1+2 Assay is an in vitro diagnostic test for the qualitative detection and differentiation of Herpes simplex virus type 1 (HSV-1) and Herpes simplex virus type 2 (HSV-2)...
Helicase Dependent Amplification Video
